Literature DB >> 23395442

Public private partnerships: a marriage of necessity.

Mahendra Rao1.   

Abstract

Harnessing the unprecedented flexibility that iPSC technology and gene editing offer academic and industry-based researchers requires developing an interactive model of collaboration. Such a model will have to leverage the basic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and high throughput technology to be successful.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh：

Year:  2013        PMID： 23395442     DOI： 10.1016/j.stem.2013.01.010

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  9 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

2.  National Institutes of Health Center for Regenerative Medicine: putting science into practice.

Authors:  Mahendra Rao
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

3.  The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

Authors:  David A Brindley; Anna French; Jane Suh; MacKenna Roberts; Benjamin Davies; Rafael Pinedo-Villanueva; Karolina Wartolowska; Kelly Rooke; Anneke Kramm; Andrew Judge; Mark Morrey; Amit Chandra; Hannah Hurley; Liam Grover; Ian Bingham; Bernard Siegel; Matt S Rattley; R Lee Buckler; David McKeon; Katie Krumholz; Lilian Hook; Michael May; Sarah Rikabi; Rosie Pigott; Megan Morys; Afsie Sabokbar; Emily Titus; Yacine Laabi; Gilles Lemaitre; Raymond Zahkia; Doug Sipp; Robert Horne; Christopher Bravery; David Williams; Ivan Wall; Evan Y Snyder; Jeffrey M Karp; Richard W Barker; Kim Bure; Andrew J Carr; Brock Reeve
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

4.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

5.  "A good collaboration is based on unique contributions from each side": assessing the dynamics of collaboration in stem cell science.

Authors:  Michael Morrison
Journal:  Life Sci Soc Policy       Date:  2017-05-04

6.  Institutional Collaboration in Plastic Surgery Research: A Solution to Resource Limitations.

Authors:  David Chi; Daniel Curiel; Alexandra Bucknor; Abbas Peymani; Anmol Chattha; Austin D Chen; Patrick Bletsis; Parisa Kamali; Samuel Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-06-06

Review 7.  Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening.

Authors:  Arun Sharma; Joseph C Wu; Sean M Wu
Journal:  Stem Cell Res Ther       Date:  2013-12-24       Impact factor: 6.832

8.  Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea.

Authors:  June Park; Eunbin Chung
Journal:  World Dev       Date:  2020-09-18

9.  Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Authors:  Hong-Kee Tan; Cheng-Xu Delon Toh; Dongrui Ma; Binxia Yang; Tong Ming Liu; Jun Lu; Chee-Wai Wong; Tze-Kai Tan; Hu Li; Christopher Syn; Eng-Lee Tan; Bing Lim; Yoon-Pin Lim; Stuart A Cook; Yuin-Han Loh
Journal:  Stem Cells Transl Med       Date:  2014-03-19       Impact factor: 6.940
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.